Platelet Rich Plasma Injection Versus Surgical Fixation Procedure in Management of Spondylolisthesis grade1.
1 other identifier
interventional
60
1 country
1
Brief Summary
Spondylolisthesis is a serious health condition that is often treated with surgery or pain-relieving lumbar epidural steroids. Patients with persistent and debilitating symptoms who have failed to respond to conservative treatment should consider surgery. Objectives: The aim of this study was to compare the therapeutic efficacy of three ultrasound guided PRP injections of the facet joint capsule to surgical procedures in patients with degenerative spondylolisthesis G1 and their effect on neurogenic pain relief and functional improvement over a one-year follow-up period. Methods: A one-year prospective randomised comparative clinical trial was performed on 60 patients with degenerative spondylolisthesis G1 who were randomly assigned to one of two groups: Group 1: thirty patients were injected in the facet joint capsule with a series of three ultrasound-guided PRP injections at four-week intervals, and Group 2: thirty patients underwent surgery. They were exposed to clinical neuropsychological testing.They were assessed for pain and function using clinical neurological assessments, VAS (Visual Analogue Scale), FRI (Functional Rating Index), Roland Morris, and ODI.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 26, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 2, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
May 26, 2020
CompletedFirst Submitted
Initial submission to the registry
March 14, 2021
CompletedFirst Posted
Study publicly available on registry
March 22, 2021
CompletedMarch 22, 2021
March 1, 2021
1.1 years
March 14, 2021
March 18, 2021
Conditions
Outcome Measures
Primary Outcomes (2)
1-Visual analogue scale. ,
VAS Visual analogue scale: According to the VAS, the pain severity was calculated by the patients on a scale of 0 (no pain) to 10 (agonising pain)
12 months
2-The Persian Functional Rating Index (FRI )
The Persian Functional Rating Index (FRI ), which is an accurate and valid instrument that contains 10 items that measure both pain and function, with an impairment score ranging from 0% (no disability) to 100% (severe disability) 2- The Persian Functional Rating Index (FRI ), which is an accurate and valid instrument that contains 10 items that measure both pain and function, with an impairment score ranging from 0% (no disability) to 100% (severe disability)
12 months
Secondary Outcomes (2)
Oswestry Disability Index (ODI) for low back pain
12 months
The Roland-Morris questionnaire
12 months
Study Arms (2)
PRP injection group
ACTIVE COMPARATORGroup 1: thirty patients were injected in the facet joint capsule with a series of three ultrasound-guided PRP injections at four-week intervals,
surgical group..
ACTIVE COMPARATORGroup 2: thirty patients underwent surgery
Interventions
Group 1: thirty patients were injected in the facet joint capsule with a series of three ultrasound-guided PRP injections at four-week intervals,
Eligibility Criteria
You may qualify if:
- Patients with degenerative spondylolithesis Grade 1 were diagnosed based on their clinical and radiological image.
- Patients complained of extreme pain and received medical treatment (NSAIDS) without improvement.
You may not qualify if:
- Patients with more than two-level pathological lesions and those who had previously
- Patients undergone lumbar surgery,
- HCV, HBV infected patients,
- patients with local abscesses,
- diabetes mellitus,
- malignancy, pregnancy,
- blood disorders (coagulopathy, thrombocytopenia),
- patients who had previously received local injection of steroid within past 3 weeks
- Patients who had undergone lumbar surgery,
- patients with advanced spondylolithesis, disc prolapse,
- inflammatory or musculoskeletal disorders of the spine.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Dalia Saif
Shebien Elkom, 11311, Egypt
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- lecturer of Rheumatology at faculty of medicine Menoufia University
Study Record Dates
First Submitted
March 14, 2021
First Posted
March 22, 2021
Study Start
March 26, 2019
Primary Completion
May 2, 2020
Study Completion
May 26, 2020
Last Updated
March 22, 2021
Record last verified: 2021-03